Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
11.33
-0.10 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
11.55
1.94%
Pre-market: Aug 18, 2025, 08:10 AM EDT
Cartesian Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -36.26M | -38.31M | -77.42M | -244.83M | -229.65M | -254.87M | -219.71M | -36.16M | -35.05M | -15.06M | 35.38M | 41.73M | 31.72M | 27.69M | -25.69M | -53.37M | -45.21M | -73.85M |
Depreciation & Amortization | 2.53M | 2.14M | 1.17M | 951K | 840K | 820K | 843K | 1.18M | 1.53M | 1.85M | 2.29M | 2M | 2.09M | 2.17M | 2.01M | 1.93M | 1.44M | 982K |
Stock-Based Compensation | 9.35M | 7.66M | 6.58M | 18.86M | 19.49M | 21.68M | 22.52M | 8.38M | 6.06M | 2.28M | n/a | n/a | n/a | n/a | n/a | 1.24M | 2.53M | 4.01M |
Other Working Capital | 654K | -8.64M | -10.84M | -15.26M | -14.74M | -14.11M | 5.26M | 3.22M | -10.22M | -22.93M | -60.63M | -90.23M | -89.23M | -83.68M | -61.11M | -33.16M | 71.41M | 82.2M |
Other Non-Cash Items | -42.21M | 4.15M | 51.79M | 76.52M | 66.81M | 65.36M | 20.51M | -5.63M | -12.31M | 13.24M | -4.59M | 1.23M | 7.74M | -19.45M | 18.41M | 27.26M | 23.24M | 32.12M |
Deferred Income Tax | n/a | n/a | n/a | 125.09M | 122.04M | 115.7M | 119.7M | -5.39M | -2.34M | 4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 32.66M | -6.5M | -5.79M | -16.55M | -42.39M | -7M | 4.97M | 1.84M | 4.22M | -29.01M | -60.38M | -91.21M | -88.56M | -67.01M | -48.19M | -10.91M | 61.86M | 73.11M |
Operating Cash Flow | -33.94M | -30.86M | -23.67M | -39.96M | -62.86M | -58.31M | -51.16M | -39.72M | -26.16M | -28.53M | -31.63M | -51.24M | -66.34M | -60.11M | -60.38M | -36.17M | 40.21M | 34.45M |
Capital Expenditures | -10.57M | -9.57M | -9.09M | -8.45M | -2.25M | -678K | -206K | -353K | -789K | -876K | -1.2M | -1.27M | -996K | -1.51M | -1.08M | -997K | -1.12M | -705K |
Cash Acquisitions | n/a | n/a | n/a | 6.56M | 6.56M | 6.56M | 6.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -33.5M | -33.5M | -33.5M | -33.5M | -8.04M | -10.04M | -32.45M | -32.45M | -24.42M | -22.42M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 28.25M | 33.95M | 37.95M | 37.95M | 19.7M | 24M | 26.4M | 26.4M | 16.4M | 6.4M | n/a | n/a |
Other Investing Acitivies | 351K | 351K | 351K | 6.56M | 6.56M | 6.56M | 6.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24K | 29K | 74K |
Investing Cash Flow | -10.22M | -9.21M | -8.74M | -1.89M | 4.31M | 5.88M | 34.61M | 33.6M | 3.66M | 3.58M | -15M | -10.77M | 17.37M | 14.85M | -17.14M | -27.03M | -25.51M | -23.05M |
Debt Repayment | n/a | n/a | n/a | n/a | -24.87M | -24.87M | -24.87M | -24.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -102K | 9.62M | 7.52M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 117.31M | 117.37M | 128.43M | 147.9M | 23.4M | 20.7M | 17.81M | -2.33M | -2.13M | 456K | 345K | 339K | 233K | 661K | 939K | 777K | 1.64M | 1.36M |
Financial Cash Flow | 117.31M | 117.37M | 168.43M | 181.73M | 32.44M | 29.74M | -13.14M | -27.23M | -1.82M | 37.64M | 39.22M | 60.37M | 61.21M | 33.32M | 52.9M | 31.55M | 51.05M | 41.11M |
Net Cash Flow | 73.16M | 77.31M | 135.99M | 139.89M | -26.11M | -22.73M | -29.75M | -33.17M | -24.36M | 12.78M | -7.33M | -1.8M | 12.31M | -11.98M | -24.63M | -31.62M | 65.73M | 52.53M |
Free Cash Flow | -44.51M | -40.43M | -32.77M | -48.41M | -65.12M | -58.99M | -51.37M | -40.08M | -26.95M | -29.41M | -32.83M | -52.51M | -67.34M | -61.63M | -61.47M | -37.17M | 39.09M | 33.74M |